Blog
RSS FeedPosted by Michael Wonder on 03 Nov 2021
Government makes a mockery of PHARMAC review
3 November 2021 - “The ACT Party can today reveal the review into PHARMAC has been delayed by more than ...
Posted by Michael Wonder on 03 Nov 2021
Major PHARMAC review delayed nearly 3 months
3 November 2021 - A major review into Government drug buying agency PHARMAC has been delayed by nearly three months. ...
Posted by Michael Wonder on 12 Oct 2021
Where is the PHARMAC Review Panel’s interim report?
12 October 2021 - Patient advocacy groups and clinicians are calling out the PHARMAC Review Panel for failing to get their ...
Posted by Michael Wonder on 11 Oct 2021
OIA documents prove PHARMAC's independent inquiry is a toothless whitewash
11 October 2021 - Following a damning survey of PHARMAC, National can also reveal documents received under OIA show the ...
Posted by Michael Wonder on 11 Oct 2021
Review of the National Medicines Policy
11 October 2021 - The call for submissions closed on Friday 8 October 2021 and a total of 107 submissions have ...
Posted by Michael Wonder on 06 Oct 2021
Where has PHARMAC gone?
7 October 2021 - As debate has intensified over the last year or so about the procurement of New Zealand’s ...
Posted by Michael Wonder on 21 Sep 2021
U.S. Food and Drug Administration reasoning in approval decisions when efficacy evidence is borderline (2013–2018)
21 September 2021 - The U.S. FDA has substantial flexibility in its approval criteria in the context of life-threatening disease and ...
Posted by Michael Wonder on 21 Sep 2021
Covid-19 delta outbreak: major PHARMAC review report delayed by lockdown
22 September 2021 - Act says it is "not good enough" an interim report for a much touted independent PHARMAC ...
Posted by Michael Wonder on 21 Sep 2021
EU-HTA regulation: methodical preparations for implementation start with IQWiG and G-BA
21 September 2021 - The institute and the G-BA are part of a consortium that is developing the methodological basis ...
Posted by Michael Wonder on 15 Sep 2021
Final report on the Australian Government response to the recommendations of the Senate Community Affairs References Committee Report
15 September 2021 - The Government acknowledges the efforts and actions detailed in this progress report to implement the Senate ...
Posted by Michael Wonder on 13 Sep 2021
Medicare Benefits Schedule continuous review to improve patient care
13 September 2021 - Medicare items and services will be reviewed by experts on an on-going basis to ensure the Medicare ...
Posted by Michael Wonder on 30 Aug 2021
Review of the National Medicines Policy – call for submissions
30 August 2021 - The National Medicines Policy Review Committee is now welcoming submissions to support the review of the National Medicines ...
Posted by Michael Wonder on 24 Aug 2021
Method paper: IQWiG puts draft version 6.1 up for discussion
23 August 2021 - The IQWiG has presented the draft for the next version of its General Methods. ...
Posted by Michael Wonder on 19 Aug 2021
NICE’s health technology assessment methods and processes to be evaluated
19 August 2021 - NICE has launched a public consultation on proposed changes to the way it develops recommendations across ...
Posted by Michael Wonder on 13 Aug 2021
Congress should fix FDA’s accelerated approval program for the next 30 years
12 August 2021 - The FDA's approval of the Alzheimer’s drug Aduhelm has sparked a broader debate on the merits ...